Refine your search:     
Report No.
 - 

Feasibility study on the production of $$^{229}$$Th as a long-life $$^{225}$$Ac generator using the experimental fast reactor Joyo

Sasaki, Yuto ; Maeda, Shigetaka   ; Fukasawa, Tetsuo*; Takaki, Naoyuki*

In recent years, targeted alpha therapy, which utilizes $$^{225}$$Ac combined with antibodies or peptides that selectively accumulate in cancer cells, has garnered attention in the field of nuclear medicine. To meet the resulting increasing demand for $$^{225}$$Ac, exploring alternative production methods is essential. While several researchers, including the authors, have explored production methods using $$^{226}$$Ra as a raw material, challenges remain, such as the limited availability of $$^{226}$$Ra, difficulties in handling it, and the requirement for regular irradiation. To address these challenges, the authors focused on developing a production strategy for a long-life $$^{225}$$Ac generator using $$^{230}$$Th as a raw material and the experimental fast reactor Joyo. A detailed investigation was conducted, encompassing chemical processing after irradiation, target availability, and production yields, including the most probable values and associated uncertainties. Results revealed that although enrichment of the raw material and long-term irradiation are required, $$^{225}$$Ac can be produced in quantities comparable to its current global supply. Furthermore, this research has shown that the THOREX method, which is already in practical use, be applied to effectively separate by-products such as fission products and radioactive materials from thorium during the chemical processing after irradiation, as revealed by a literature survey.

Accesses

:

- Accesses

InCites™

:

Percentile:0.00

Category:Nuclear Science & Technology

Altmetrics

:

[CLARIVATE ANALYTICS], [WEB OF SCIENCE], [HIGHLY CITED PAPER & CUP LOGO] and [HOT PAPER & FIRE LOGO] are trademarks of Clarivate Analytics, and/or its affiliated company or companies, and used herein by permission and/or license.